Historical record - last NADAC effective date: 4/17/2024

Product Information

ROSUVASTATIN CALCIUM 20 MG TAB is a generic product labeled by Accord Healthcare Inc., priced at $0.0574 per EA under NDC 16729028615. Its NADAC has been published 391 times since Nov 23, 2016.

FDA first approved this application on Oct 31, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ROSUVASTATIN CALCIUM 20 MG TAB

Rosuvastatin
$0.0574per EA

Strength

20 mg/1

NDC

16729028615

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

4/17/2024

Active Ingredients

ROSUVASTATIN CALCIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA206434

FDA Approved

10/31/2016

TE Code

AB

On Market Since

10/31/2016

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for ROSUVASTATIN CALCIUM 20 MG TAB has been published 391 times since Nov 23, 2016, and over the history we have for it it has declined 79.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0574 per EA
All-time high$0.3002 (Jan 11, 2017)
All-time low$0.0574 (Apr 17, 2024)
Median price$0.0941
Average price$0.1071
Largest weekly change-22.3% (Jan 18, 2017)
Weeks tracked391
Tracking sinceNov 23, 2016

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

-21.2%

5Y

-28.7%

All

-79.8%

Last surveyed May 15, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ROSUVASTATIN CALCIUM 20 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for ROSUVASTATIN CALCIUM 20 MG TAB, manufactured by Accord Healthcare Inc., is $0.0574 per EA (NDC 16729028615), effective May 15, 2024.

How has the price of ROSUVASTATIN CALCIUM 20 MG TAB changed over time?

Over the history we have for it, the NADAC for ROSUVASTATIN CALCIUM 20 MG TAB has declined 79.8%. It has been tracked across 391 weekly CMS publications since Nov 23, 2016.

What are the highest and lowest recorded NADAC prices for ROSUVASTATIN CALCIUM 20 MG TAB?

Since Nov 23, 2016, the NADAC for ROSUVASTATIN CALCIUM 20 MG TAB has ranged from a low of $0.0574 (Apr 17, 2024) to a high of $0.3002 (Jan 11, 2017), with a median of $0.0941 per EA.

Are there cheaper alternatives to ROSUVASTATIN CALCIUM 20 MG TAB?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ROSUVASTATIN CALCIUM 20 MG TAB, is $0.0449 per EA — about 22% below ROSUVASTATIN CALCIUM 20 MG TAB.

Who manufactures ROSUVASTATIN CALCIUM 20 MG TAB?

ROSUVASTATIN CALCIUM 20 MG TAB (NDC 16729028615) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.